Your body is not a snapshot.
ENDARIA connects every signal you already have, your blood tests, wearables, symptoms and treatment, into one longitudinal picture. Bring every signal. See one pattern.
Bring every signal. See one pattern.
Everyone else is racing to build the one sensor. ENDARIA is the intelligence layer that sits above them. It doesn't matter where your data comes from, ENDARIA turns it into one longitudinal, clinician-ready picture, and it only gets richer over time.
Bring your data
See one picture
One signal rarely tells the whole story. Connected, over time, they begin to.
This is a preview of the ENDARIA view, physiology, symptoms and hormone information read together, not as isolated moments.
Your last 90 days
From scattered signals to a story you can act on.
Watch how a month of small, disconnected changes becomes a single, legible pattern, the difference between "I think it got worse" and a clear record you can bring to your clinician.
Your body is already sending signals.
Sleep, temperature, heart-rate patterns and symptoms, gathered quietly in the background.
"Possible vasomotor event, 2:14 am."
ENDARIA flags probable events and learns from your confirmation, becoming personal to you.
Signals read together, over time.
Sleep, symptoms, hormones and treatment on one timeline, associations, not false certainty.
Walk in with the last 90 days.
A clear, clinician-ready summary, so the conversation starts with facts, not memory.
What if your next appointment started with the last 90 days?
ENDARIA generates a structured summary that organises symptoms, sleep, treatment and hormone information, built to support clinical judgement, never to replace it.
Measure. Connect. Explain. Prepare.
Measure over time
A physiological wearable and optional at-home testing capture what a single test can't, change, continuously.
Connect the signals
Hormones, sleep, temperature, cognition, mood and treatment, read together, with associations made honest.
Prepare your visit
A clear, shareable 90-day summary so appointments start with facts instead of trying to remember.
One idea, built in stages.
ENDARIA is the intelligence layer. LAB and SIGNAL are your own data sources that plug into it over time, not a bet on one device working on day one.
The device-agnostic intelligence layer. Bring any data, blood tests, wearables, at-home tests, symptoms and treatment, and see one longitudinal picture.
A minimally invasive wearable sensor being developed for longitudinal hormone measurement.
A portable hormone-testing platform, a reusable reader with disposable cartridges.
The clinician-facing platform that organises longitudinal information between appointments.
The research and life-sciences platform, for longitudinal hormone research, treatment-response studies and pharmaceutical partnerships. Menopause is the first market; female hormonal health is the platform.
A large, underserved market with real momentum.
Indicative third-party estimates (SVB, Dealroom, FP Analytics, Australian Government). Menopause is the fastest-rising femtech sub-sector, and women's-health exits since 2000 total more than US$100 billion.
Built on where the evidence actually is.
ENDARIA is designed to be scientifically responsible, it shows patterns and associations, and never claims certainty the science can't yet support. It also answers a real gap, only about one in five US OB-GYNs report formal menopause training.
No single test defines the stage.
Hormones fluctuate through perimenopause; a single result often can't clarify the picture. So ENDARIA sells the pattern, not one number.
Continuous hormone sensing is coming.
From Caltech's sweat-based estradiol sensor to a 2026 University of Melbourne wearable hormone biosensor with menopause applications, the science is moving fast.
Transparent by default.
Every insight distinguishes measurement from estimate, association from conclusion. Explainable, not a black box.
The things women ask us first.
No. ENDARIA helps you see and organise patterns over time and prepare for conversations with your clinician. It supports clinical judgement, it doesn't replace it, and it won't claim a diagnosis from a single reading.
The first product connects symptoms, sleep, temperature, heart-rate patterns, activity, cognition, mood, treatment and optional at-home hormone information. Continuous hormone sensing (ENDARIA SIGNAL) is in development.
Privacy is built in from the start, not buried in a footer. Your data is yours, with explicit consent, clear controls, and no selling of your information as a hidden product.
We're onboarding The First 1,000 now, early access, research updates and a hand in shaping the product. Join below to claim a place.
Help build what should already exist.
Join the first 1,000 women shaping the future of women's health, early access, research updates, and a hand in what ENDARIA becomes.
Building the continuous hormone intelligence layer for women's health.
ENDARIA HEALTH is developing a staged platform: longitudinal health intelligence, physiological monitoring, portable biochemical testing, and future continuous hormone sensing. Menopause is the first market. Female hormonal health is the larger platform.
- Non-dilutive first: grants and research partnerships before priced equity.
- A defensible moat in sensor IP, clinical evidence and longitudinal data.
- Category timing: women's health capital and wearable biosensing are both accelerating.
Request the investor materials
Register your interest and we'll follow up with the deck and a data room invitation.